OpenAI says its board of directors has unanimously rejected a $97.4 billion takeover bid by Elon Musk. “OpenAI is not for sale, and the board has unanimously rejected Mr.
Tevogen Bio remains steadfast in its mission to pioneer accessible and affordable precision medicine while advocating for fair and transparent market participation.
Sylogist's new logo growth and cross-selling strategies make it an attractive investment with strong IRR potential despite near-term headwinds. See more here.
People have found it hard to know when Together mode is on. Now, with new buttons (Everyone, Change scene, and Assign seats), ...
Former USMNT goalkeeper Tim Howard shares his thoughts on how MLS goalkeepers can stop Inter Miami’s Lionel Messi. The new ...
MAXHUB XBoard V7 for Teams and UC P30 have undergone a series of stringent Microsoft compatibility and certification ...
Microsoft Clipchamp will have an enhanced brand kit that should give users all the tools to create branded content in the ...
After touting a ChatGPT Enterprise use case with USAID, it’s not clear what’s next for the AI company and the disappearing ...
4d
MSI has refreshed the Prestige 16 AI Evo with the latest Intel Core Ultra 200H series processors, offering over 15 hours of ...
After receiving countless job rejections, Akshay Phadké, a software engineer, used four résumé strategies to help him land a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback